-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
-
Summary
-
Oncology Institute, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q1 2021 to Q2 2025.
- Oncology Institute, Inc. Nonoperating Income (Expense) for the quarter ending June 30, 2025 was -$5.93M, a 770% decline year-over-year.
- Oncology Institute, Inc. Nonoperating Income (Expense) for the twelve months ending June 30, 2025 was -$19.1M, a 134% decline year-over-year.
- Oncology Institute, Inc. annual Nonoperating Income (Expense) for 2024 was -$4.55M, a 25.3% increase from 2023.
- Oncology Institute, Inc. annual Nonoperating Income (Expense) for 2023 was -$6.09M, a 107% decline from 2022.
- Oncology Institute, Inc. annual Nonoperating Income (Expense) for 2022 was $81.9M, a 139% increase from 2021.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)